High materiality7/10
Summit Therapeutics upgraded to Buy from Hold at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies upgrades SMMT to Buy from Hold; target $25; posted price $17.28; implies upside.
- Jefferies upgrades SMMT to Buy; target $25 vs price $17.28.
Key facts
- 01
Target: $25
- 02
Posted price: $17.28
- 03
Analyst firm: Summit Redstone Partners
- 04
Analyst: Faisal Khurshid
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.